The document discusses the demographics and predictive modeling for diabetic treatments in the U.S., focusing on the significant market of 30.35 million diabetic individuals. It utilizes logistic regression and k-nearest neighbors to analyze data from over 229,000 respondents, highlighting that k-NN provided the best predictive outcomes with 87% accuracy. Recommendations emphasize the need for pharmaceutical companies to target treatments based on demographic segmentation due to the predominance of type 2 diabetes.
Related topics: